Live Telecast, "STEM CELL THERAPY & NEUROLOGICAL DISORDERS" on 21st April 2018 at 3.30 PM on Z-24TAAS_HITGUJ By Dr. Anant Bagul   :*: Upcomming Events: “2ND INTERNATIONAL REGENERATIVE MEDICINE CONCLAVE ON 13TH MAY 2018”  

Optic Nerve Atrophy Disease

The discovery of the stem cell has lead to a revolution in modern medicine. Stem cells are in fact, they are the "basic cells" of our bodies, which can develop and differentiate in any type of cell.

These cells migrate to injured areas within the body and get transplanted and transform themselves into new tissue cells that replace the damaged ones. Stem cells have the capacity to multiply and to renew themselves almost indefinitely. This contrasts with nerve cells, muscle cells and blood cells, which cannot multiply themselves and have limited life spans.

Retinitis pigmentosa (RP) is a group of inherited disorders characterized by progressive peripheral vision loss and night vision difficulties (nyctalopia) that can lead to central vision loss.

It is a group of genetic eye conditions that leads to incurable blindness. Symptoms often first appear in childhood, but severe vision problems do not usually develop until early adulthood.
  • Decreased vision at night or in low light
  • Loss of side (peripheral) vision, causing "tunnel vision"
  • Loss of central vision (in advanced cases)

There is no effective clinical trial for this condition. Wearing sunglasses to protect the retina from ultraviolet light may help preserve vision.

The Chaitanya stem Cell-Center's clinical trial is unique because it focuses on repairing tissue damage and restoring function to improve each patient's quality of life.

There are a number of advantages to using human stem cells that do not require immune suppression and which can help balance immune function by changing the genetics of the immune reactive cells.



Patients clinical by retrobulbular injection of a 1-ml cell suspension containing mesenchymal stem cell also 3 doses by intravenous route.
Retinitis Pigmentosa research Retinitis Pigmentosa research